DBV TECHNOLOGIES SA (DBV.PA) Stock Price, Quote, News and Overview
EPA:DBV - Euronext Paris - Matif - FR0010417345 - Common Stock - Currency: EUR
DBV.PA Quote, Performance and Key Statistics
EPA:DBV (5/12/2025, 7:00:00 PM)
1.942
+0.15 (+8.61%)
The current stock price of DBV.PA is 1.942 EUR. In the past month the price increased by 61.83%. In the past year, price increased by 52.91%.
DBV.PA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 4AB.DE | ABBVIE INC | 18.88 | 304.97B | ||
| AMG.DE | AMGEN INC | 13.37 | 132.64B | ||
| 1GILD.MI | GILEAD SCIENCES INC | 13.44 | 115.15B | ||
| GIS.DE | GILEAD SCIENCES INC | 13.21 | 113.16B | ||
| VX1.DE | VERTEX PHARMACEUTICALS INC | N/A | 98.73B | ||
| 1REGN.MI | REGENERON PHARMACEUTICALS | 11.87 | 52.64B | ||
| ARGX.BR | ARGENX SE | 104.99 | 30.45B | ||
| 22UA.DE | BIONTECH SE-ADR | N/A | 20.88B | ||
| IDP.DE | BIOGEN INC | 7.52 | 15.50B | ||
| 1MRNA.MI | MODERNA INC | N/A | 8.85B | ||
| 0QF.DE | MODERNA INC | N/A | 8.75B | ||
| BIO.DE | BIOTEST AG | 65.54 | 1.69B |
Related stock screener links
About DBV.PA
Company Profile
DBV Technologies SA is a clinical-stage biopharmaceutical company, which engages in the research and development of epicutaneous immunotherapy products. The company is headquartered in Chatillon, Auvergne-Rhone-Alpes and currently employs 110 full-time employees. The company went IPO on 2012-03-29. The firm's therapeutic approach is based on epicutaneous immunotherapy, or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin. The company dedicates its technology to treat patients, including infants and children, suffering from severe food allergies, for whom safety is paramount, since the introduction of the offending allergen into their bloodstream can cause severe or life-threatening allergic reactions, such as anaphylactic shock. The firm's product portfolio for allergy treatments consists of Viaskin Peanut, Viaskin Milk and Viaskin Egg. The firm operates one subsidiary DBV Technologies Inc. in the United States.
Company Info
DBV TECHNOLOGIES SA
Batiment IRO, 107 Av. de la Republique
Chatillon AUVERGNE-RHONE-ALPES FR
Employees: 110
Phone: 33155427878
DBV TECHNOLOGIES SA / DBV.PA FAQ
What is the stock price of DBV TECHNOLOGIES SA today?
The current stock price of DBV.PA is 1.942 EUR. The price increased by 8.61% in the last trading session.
What is the ticker symbol for DBV TECHNOLOGIES SA stock?
The exchange symbol of DBV TECHNOLOGIES SA is DBV and it is listed on the Euronext Paris - Matif exchange.
On which exchange is DBV.PA stock listed?
DBV.PA stock is listed on the Euronext Paris - Matif exchange.
What is the price forecast or stock price prediction for DBV TECHNOLOGIES SA stock?
7 analysts have analysed DBV.PA and the average price target is 4.84 EUR. This implies a price increase of 149.31% is expected in the next year compared to the current price of 1.942. Check the DBV TECHNOLOGIES SA stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is DBV TECHNOLOGIES SA worth?
DBV TECHNOLOGIES SA (DBV.PA) has a market capitalization of 53.09M EUR. This makes DBV.PA a Micro Cap stock.
How many employees does DBV TECHNOLOGIES SA have?
DBV TECHNOLOGIES SA (DBV.PA) currently has 110 employees.
Is DBV TECHNOLOGIES SA (DBV.PA) expected to grow?
The Revenue of DBV TECHNOLOGIES SA (DBV.PA) is expected to grow by 2860% in the next year. Check the estimates tab for more information on the DBV.PA EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy DBV TECHNOLOGIES SA (DBV.PA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of DBV.PA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of DBV.PA, evaluating the profitability, health, valuation and growth aspects
- DBV TECHNOLOGIES SA (DBV.PA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- DBV TECHNOLOGIES SA (DBV.PA) Sales and EPS estimates to see what analysts future expectations are.
- DBV TECHNOLOGIES SA (DBV.PA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- DBV TECHNOLOGIES SA (DBV.PA) Insider and Institutional Ownership to learn about the owners and their transactions.
- DBV TECHNOLOGIES SA (DBV.PA) Stock Chart to make your own analysis
- DBV TECHNOLOGIES SA (DBV.PA) Latest news and press-releases to stay up to date.
Does DBV TECHNOLOGIES SA (DBV.PA) stock pay dividends?
DBV.PA does not pay a dividend.
When does DBV TECHNOLOGIES SA (DBV.PA) report earnings?
DBV TECHNOLOGIES SA (DBV.PA) will report earnings on 2025-07-28.
What is the Price/Earnings (PE) ratio of DBV TECHNOLOGIES SA (DBV.PA)?
DBV TECHNOLOGIES SA (DBV.PA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.05).
DBV.PA Technical Analysis
ChartMill assigns a technical rating of 9 / 10 to DBV.PA. When comparing the yearly performance of all stocks, DBV.PA is one of the better performing stocks in the market, outperforming 98.91% of all stocks.
DBV.PA Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to DBV.PA. DBV.PA has a bad profitability rating. Also its financial health evaluation is rather negative.
DBV.PA Financial Highlights
Over the last trailing twelve months DBV.PA reported a non-GAAP Earnings per Share(EPS) of -1.05. The EPS decreased by -53.92% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -174.12% | ||
| ROE | -416.74% | ||
| Debt/Equity | 0.23 |
DBV.PA Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 89% to DBV.PA. The Buy consensus is the average rating of analysts ratings from 7 analysts.
For the next year, analysts expect an EPS growth of -5.31% and a revenue growth 2860% for DBV.PA